As of November 2024, Novo Nordisk has a market cap of $604.51B. This makes Novo Nordisk the world's 13th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $545.87B | 17.71% |
2023 | $463.75B | -23.56% |
2022 | $606.70B | 20.84% |
2021 | $502.07B | 60.34% |
2020 | $313.12B | 20.68% |
2019 | $259.46B | 25.63% |
2018 | $206.52B | -14.16% |
2017 | $240.59B | 49.67% |
2016 | $160.75B | -38.26% |
2015 | $260.36B | 37.24% |
2014 | $189.71B | 14.53% |
2013 | $165.65B | 13.20% |
2012 | $146.33B | 41.60% |
2011 | $103.34B | 2.39% |
2010 | $100.93B | 76.30% |
2009 | $57.25B | 24.25% |
2008 | $46.07B | -20.77% |
2007 | $58.15B | 55.11% |
2006 | $37.49B | 48.60% |
2005 | $25.23B | 3.72% |
2004 | $24.32B | 32.47% |
2003 | $18.36B | 41.73% |
2002 | $12.96B | -27.93% |
2001 | $17.98B | 13.28% |
2000 | $15.87B | 36.94% |
1999 | $11.59B | -2.82% |
1998 | $11.92B | -7.80% |
1997 | $12.93B | 54.28% |
1996 | $8.38B | 36.50% |
1995 | $6.14B | 44.21% |
1994 | $4.26B | -4.04% |
1993 | $4.44B | 11.55% |
1992 | $3.98B | -0.84% |
1991 | $4.01B | 43.49% |
1990 | $2.80B | 24.44% |
1989 | $2.25B | 29.35% |
1988 | $1.74B | 81.29% |
1987 | $958.20M | -34.98% |
1986 | $1.47B | 11.91% |
1985 | $1.32B | 23.68% |
1984 | $1.06B | -57.59% |
1983 | $2.51B | 27.64% |
1982 | $1.97B | 10.03% |
1981 | $1.79B | - |